STVN
Stevanato Group S.p.A.
Price Chart
Latest Quote
$19.79
-0.31 (-1.54%)
Current Price
| Previous Close | $20.10 |
| Open | $19.79 |
| Day High | $20.00 |
| Day Low | $19.91 |
| Volume | 6,201 |
Stock Information
Note: Financial values converted from EUR to USD
| Quarterly Dividend / Yield | $0.06 / 0.31% |
| Shares Outstanding | 49.71M |
| Quarterly Dividend Yield | 0.31% |
| Quarterly Dividend | $0.06 |
| Total Debt | $515.72M |
| Cash Equivalents | $128.51M |
| Revenue | $1.38B |
| Net Income | $161.78M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $5.23B |
| P/E Ratio | 33.05 |
| EPS (TTM) | $0.58 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $5.57B |
| Sales | $1.38B |
| Income | $161.78M |
| Book/sh | $6.41 |
| Cash/sh | $2.26 |
| Employees | 6K |
Financial Ratios
| Quick Ratio | 1.10 |
| Current Ratio | 1.63 |
| Debt/Eq | 29.43 |
| EPS Growth TTM | 5.70% |
Returns & Margins
| ROA | 5.27% |
| ROE | 9.59% |
| Gross Margin | 29.22% |
| Operating Margin | 14.24% |
| Profit Margin | 11.75% |
Ownership
| Insider Ownership | 1.65% |
| Institutional Ownership | 97.37% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 22.99 |
| PEG | 3.57 |
| P/S | 4.35 |
| P/B | 2.99 |
Analyst Data
| Recommendation | buy |
| Target Price | $24.45 |
Technical Indicators
| SMA20 | $18.64 |
| SMA50 | $18.20 |
| SMA200 | $18.96 |
| RSI | 59.71 |
| ATR | 0.8564 |
| Shares Float | 48.90M |
| Short Float | 1.93% |
| Short Ratio | 2.44 |
| Volatility | 0.78 |
| Rel Volume | 0.90 |
Performance History
| Week | -2.14% |
| Month | +16.11% |
| Quarter | +28.00% |
| 6 Months | -5.97% |
| YTD | -6.52% |
| Year | -24.64% |
| 3 Years | -39.54% |
| 10 Years | -1.07% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $19.17 | 268,800 |
| 2026-07-16 | $20.10 | 234,900 |
| 2026-07-15 | $18.90 | 221,800 |
| 2026-07-14 | $19.82 | 254,200 |
| 2026-07-13 | $19.78 | 174,200 |
| 2026-07-10 | $19.59 | 353,500 |
| 2026-07-09 | $19.75 | 298,600 |
| 2026-07-08 | $19.32 | 298,500 |
| 2026-07-07 | $19.59 | 483,700 |
| 2026-07-06 | $19.28 | 234,700 |
| 2026-07-02 | $19.00 | 336,500 |
| 2026-07-01 | $18.34 | 232,000 |
| 2026-06-30 | $18.07 | 324,000 |
| 2026-06-29 | $17.36 | 254,500 |
| 2026-06-26 | $17.84 | 328,000 |
| 2026-06-25 | $18.39 | 243,100 |
| 2026-06-24 | $17.24 | 473,000 |
| 2026-06-23 | $16.87 | 295,700 |
| 2026-06-22 | $16.94 | 381,200 |
| 2026-06-18 | $17.54 | 263,900 |
About Stevanato Group S.p.A.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
đ° Latest News
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?
Zacks âĸ 2026-07-07T11:38:00Z
TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN)
Insider Monkey âĸ 2026-07-01T13:28:31Z
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
Zacks âĸ 2026-06-23T11:08:00Z
Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness
Simply Wall St. âĸ 2026-06-14T10:10:49Z
Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now?
Insider Monkey âĸ 2026-06-11T17:18:27Z
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
Motley Fool âĸ 2026-06-09T15:05:00Z
Implied Volatility Surging for Stevanato Stock Options
Zacks âĸ 2026-06-03T15:50:00Z
Earnings Beat: Stevanato Group S.p.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Simply Wall St. âĸ 2026-05-09T14:02:37Z
Stevanato (STVN) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-08T15:58:10Z
Stevanato Group S.p.A. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-08T12:30:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $874,712,606 | $837,864,347 | $775,326,219 | $761,416,368 |
| Cost Of Revenue | $966,172,626 | $919,505,582 | $854,984,428 | $761,416,368 |
| Total Revenue | $1,360,571,026 | $1,266,241,411 | $1,244,814,644 | $1,128,202,659 |
| Operating Revenue | $1,360,571,026 | $1,266,241,411 | $1,244,814,644 | $1,128,202,659 |
| Expenses | ||||
| Interest Expense | $7,435,485 | $7,872,462 | $4,948,962 | $4,514,279 |
| Total Expenses | $1,132,562,104 | $1,081,424,364 | $1,014,604,781 | $907,499,620 |
| Other Income Expense | $-4,507,397 | $5,716,251 | $-8,528,500 | $-1,589,632 |
| Net Non Operating Interest Income Expense | $-6,611,996 | $-6,695,721 | $-4,279,160 | $-3,904,117 |
| Total Other Finance Cost | $357,839 | $799,404 | $238,559 | $133,043 |
| Interest Expense Non Operating | $7,435,485 | $7,872,462 | $4,948,962 | $4,514,279 |
| Operating Expense | $166,389,477 | $161,918,781 | $159,620,353 | $146,083,251 |
| Other Operating Expenses | $-9,455,212 | $-10,426,653 | $-11,954,351 | $-21,619,450 |
| Selling And Marketing Expense | $31,727,259 | $27,825,436 | $27,844,933 | $29,918,566 |
| General And Administrative Expense | $104,826,231 | $97,339,134 | $92,464,723 | $98,344,984 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $160,384,202 | $135,081,991 | $167,027,165 | $163,836,432 |
| Net Interest Income | $-6,611,996 | $-6,695,721 | $-4,279,160 | $-3,904,117 |
| Interest Income | $1,181,328 | $1,976,144 | $908,361 | $743,204 |
| Normalized Income | $163,715,168 | $130,880,546 | $173,585,581 | $165,047,732 |
| Net Income From Continuing And Discontinued Operation | $160,384,202 | $135,081,991 | $167,027,165 | $163,836,432 |
| Total Operating Income As Reported | $228,008,922 | $184,817,047 | $230,209,863 | $220,703,039 |
| Net Income Common Stockholders | $160,384,202 | $135,081,991 | $167,027,165 | $163,836,432 |
| Net Income | $160,384,202 | $135,081,991 | $167,027,165 | $163,836,432 |
| Net Income Including Noncontrolling Interests | $160,375,026 | $135,068,228 | $167,094,833 | $164,027,968 |
| Net Income Continuous Operations | $160,375,026 | $135,068,228 | $167,094,833 | $164,027,968 |
| Pretax Income | $216,889,529 | $183,837,577 | $217,402,203 | $215,209,291 |
| Interest Income Non Operating | $1,181,328 | $1,976,144 | $908,361 | $743,204 |
| Operating Income | $228,008,922 | $184,817,047 | $230,209,863 | $220,703,039 |
| Depreciation Amortization Depletion Income Statement | $10,118,132 | $10,860,189 | $10,352,104 | - |
| Depreciation And Amortization In Income Statement | $10,118,132 | $10,860,189 | $10,352,104 | - |
| Gross Profit | $394,398,399 | $346,735,828 | $389,830,216 | $366,786,291 |
| Special Income Charges | - | - | $0 | $0 |
| Earnings From Equity Interest | - | - | $0 | $0 |
| Per Share | ||||
| Diluted EPS | $0.58 | $0.49 | $0.63 | $0.62 |
| Basic EPS | $0.58 | $0.49 | $0.63 | $0.62 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,176,431 | $1,514,807 | $-1,970,084 | $-378,332 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $330,410,563 | $278,495,212 | $320,889,977 | $295,660,022 |
| Total Unusual Items | $-4,507,397 | $5,716,251 | $-8,528,500 | $-1,589,632 |
| Total Unusual Items Excluding Goodwill | $-4,507,397 | $5,716,251 | $-8,528,500 | $-1,589,632 |
| Reconciled Depreciation | $101,578,152 | $92,501,424 | $90,010,313 | $74,346,821 |
| EBITDA (Bullshit earnings) | $325,903,166 | $284,211,463 | $312,361,477 | $294,070,391 |
| EBIT | $224,325,014 | $191,710,039 | $222,351,164 | $219,723,569 |
| Diluted Average Shares | $313,109,269 | $311,044,812 | $303,908,154 | $303,589,830 |
| Basic Average Shares | $313,109,269 | $310,930,120 | $303,878,129 | $303,589,830 |
| Diluted NI Availto Com Stockholders | $160,384,202 | $135,081,991 | $167,027,165 | $163,836,432 |
| Minority Interests | $9,175 | $13,763 | $-67,668 | $-191,536 |
| Tax Provision | $56,514,503 | $48,769,349 | $50,307,370 | $51,181,323 |
| Gain On Sale Of Security | $-4,507,397 | $5,716,251 | $-8,528,500 | $-1,589,632 |
| Research And Development | $29,173,067 | $36,320,675 | $40,912,945 | $39,439,152 |
| Selling General And Administration | $136,553,490 | $125,164,570 | $120,309,656 | $128,263,549 |
| Other Gand A | $104,826,231 | $97,339,134 | $92,464,723 | $98,344,984 |
| Gain On Sale Of Business | - | - | $0 | $0 |
Fetched: 2026-07-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,605,268,787 | $1,514,813,469 | $1,206,059,057 | $1,051,415,191 |
| Total Assets | $2,917,735,678 | $2,670,970,019 | $2,375,933,921 | $1,903,541,494 |
| Total Non Current Assets | $1,835,788,318 | $1,661,538,996 | $1,387,412,404 | $933,504,893 |
| Non Current Deferred Assets | $119,132,916 | $109,351,979 | $87,453,827 | $79,378,361 |
| Non Current Deferred Taxes Assets | $119,132,916 | $109,351,979 | $87,453,827 | $79,378,361 |
| Financial Assets | $389,953 | $0 | $661,773 | $3,205,643 |
| Investmentin Financial Assets | $6,469,778 | $6,469,778 | $5,907,787 | $2,094,277 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $5,022,364 | $4,745,957 | $4,424,819 | $896,892 |
| Goodwill And Other Intangible Assets | $99,608,890 | $95,851,579 | $92,863,851 | $91,066,627 |
| Other Intangible Assets | $42,282,367 | $38,525,056 | $35,537,329 | $36,882,666 |
| Current Assets | $1,081,947,359 | $1,009,431,023 | $988,521,517 | $970,036,601 |
| Hedging Assets Current | $2,226,172 | $815,460 | $4,166,762 | $6,530,565 |
| Assets Held For Sale Current | $0 | $254,616 | $0 | - |
| Prepaid Assets | $3,543,984 | $6,689,987 | $11,591,924 | $806,285 |
| Inventory | $307,657,957 | $281,244,380 | $292,832,863 | $244,585,363 |
| Receivables | $618,728,001 | $607,718,712 | $599,242,971 | $423,759,562 |
| Other Receivables | $233,956,852 | $215,723,111 | $213,980,939 | $131,821,296 |
| Taxes Receivable | $37,327,671 | $51,854,565 | $39,157,009 | $47,949,301 |
| Accrued Interest Receivable | $284,436 | $708,797 | $0 | - |
| Accounts Receivable | $347,159,042 | $339,432,239 | $346,105,022 | $243,988,964 |
| Allowance For Doubtful Accounts Receivable | $-8,124,784 | $-7,688,954 | $-7,633,902 | $-6,836,793 |
| Gross Accounts Receivable | $355,283,826 | $347,121,194 | $353,738,924 | $250,825,757 |
| Cash Cash Equivalents And Short Term Investments | $149,791,245 | $112,707,868 | $80,686,997 | $294,354,827 |
| Cash And Cash Equivalents | $149,791,245 | $112,707,868 | $79,827,954 | $262,346,572 |
| Non Current Accounts Receivable | - | - | - | - |
| Debt | ||||
| Net Debt | $372,224,987 | $359,902,475 | $353,299,654 | - |
| Total Debt | $537,796,710 | $491,994,444 | $454,856,015 | $250,448,420 |
| Long Term Debt And Capital Lease Obligation | $398,163,739 | $363,615,056 | $292,637,887 | $170,211,016 |
| Long Term Debt | $387,409,067 | $350,071,073 | $277,608,642 | $153,400,604 |
| Current Debt And Capital Lease Obligation | $139,632,971 | $128,379,388 | $162,218,128 | $80,237,404 |
| Current Debt | $134,607,166 | $122,539,269 | $155,518,965 | $74,130,053 |
| Other Current Borrowings | $100,198,407 | $65,158,842 | $59,171,917 | $58,939,092 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,212,814,418 | $1,060,252,213 | $1,076,879,118 | $761,311,998 |
| Total Non Current Liabilities Net Minority Interest | $598,205,008 | $512,627,542 | $418,101,803 | $230,859,020 |
| Other Non Current Liabilities | $59,817,633 | $71,934,847 | $55,595,819 | $20,713,382 |
| Derivative Product Liabilities | $238,559 | $736,323 | $559,697 | $0 |
| Non Current Deferred Liabilities | $128,577,805 | $64,922,576 | $56,247,270 | $24,030,276 |
| Non Current Deferred Taxes Liabilities | $15,207,018 | $14,405,320 | $11,037,962 | $24,030,276 |
| Current Liabilities | $614,609,410 | $547,624,671 | $658,777,315 | $530,452,979 |
| Other Current Liabilities | $10,596,398 | $12,967,082 | $11,567,839 | $10,030,966 |
| Current Deferred Liabilities | $65,343,496 | $51,231,787 | $67,441,213 | $61,802,953 |
| Payables And Accrued Expenses | $393,996,977 | $350,299,310 | $416,330,958 | $378,381,656 |
| Payables | $393,996,977 | $350,299,310 | $416,330,958 | $378,381,656 |
| Other Payable | $57,949,300 | $48,564,050 | $50,529,872 | $51,378,593 |
| Total Tax Payable | $34,054,361 | $36,773,709 | $47,169,395 | $52,683,789 |
| Accounts Payable | $301,993,317 | $264,961,551 | $318,631,691 | $274,319,274 |
| Equity | ||||
| Common Stock Equity | $1,704,877,677 | $1,610,665,048 | $1,298,922,908 | $1,142,481,818 |
| Total Equity Gross Minority Interest | $1,704,921,260 | $1,610,717,806 | $1,299,054,803 | $1,142,229,496 |
| Stockholders Equity | $1,704,877,677 | $1,610,665,048 | $1,298,922,908 | $1,142,481,818 |
| Other Equity Interest | $-1,147 | - | $167,027,165 | $163,836,432 |
| Gains Losses Not Affecting Retained Earnings | $-67,279,498 | $-15,770,156 | $-10,442,710 | $-12,034,636 |
| Other Equity Adjustments | $-224,796 | $-1,344,191 | $2,145,888 | $5,869,939 |
| Retained Earnings | $1,135,940,931 | $990,296,950 | $869,203,947 | $714,936,272 |
| Long Term Equity Investment | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $34,222,777 | $34,343,282 | $34,491,444 | $35,371,662 |
| Ordinary Shares Number | $313,113,506 | $312,993,000 | $304,469,452 | $303,589,235 |
| Share Issued | $347,336,283 | $347,336,283 | $304,469,452 | $338,960,896 |
| Tangible Book Value | $1,605,268,787 | $1,514,813,469 | $1,206,059,057 | $1,051,415,191 |
| Invested Capital | $2,226,893,909 | $2,083,275,390 | $1,732,050,515 | $1,370,012,475 |
| Working Capital | $467,337,949 | $461,806,352 | $329,744,203 | $439,583,622 |
| Capital Lease Obligations | $15,780,478 | $19,384,102 | $21,728,407 | $22,917,763 |
| Total Capitalization | $2,092,286,744 | $1,960,736,121 | $1,576,531,550 | $1,295,882,422 |
| Minority Interest | $43,583 | $52,758 | $131,896 | $-252,322 |
| Foreign Currency Translation Adjustments | $-67,054,701 | $-14,425,965 | $-12,588,598 | $-17,904,574 |
| Treasury Stock | $31,057,458 | $31,136,595 | $31,234,083 | $31,815,572 |
| Additional Paid In Capital | $641,776,514 | $641,776,514 | $446,509,875 | $446,509,875 |
| Capital Stock | $25,498,334 | $25,498,334 | $24,885,879 | $24,885,879 |
| Common Stock | $25,498,334 | $25,498,334 | $24,885,879 | $24,885,879 |
| Employee Benefits | $7,780,708 | $8,215,391 | $8,502,121 | $9,536,643 |
| Non Current Deferred Revenue | $113,370,788 | $50,517,256 | $45,209,308 | $0 |
| Long Term Capital Lease Obligation | $10,754,673 | $13,543,983 | $15,029,245 | $16,810,412 |
| Long Term Provisions | $3,626,562 | $3,203,349 | $4,559,009 | $6,367,702 |
| Current Deferred Revenue | $65,343,496 | $51,231,787 | $67,441,213 | $61,802,953 |
| Current Capital Lease Obligation | $5,025,805 | $5,840,119 | $6,699,162 | $6,107,351 |
| Line Of Credit | $34,408,759 | $57,380,428 | $96,347,048 | $15,190,961 |
| Current Provisions | $5,039,568 | $4,747,104 | $1,219,176 | - |
| Investments And Advances | $6,469,778 | $6,469,778 | $5,907,787 | $2,094,277 |
| Available For Sale Securities | $1,447,414 | $1,723,821 | $1,482,968 | $1,197,385 |
| Goodwill | $57,326,522 | $57,326,522 | $57,326,522 | $54,183,960 |
| Net PPE | $1,610,186,782 | $1,449,865,661 | $1,200,525,166 | $757,759,986 |
| Accumulated Depreciation | $-719,222,314 | $-647,485,883 | $-583,073,687 | $-500,143,313 |
| Gross PPE | $2,329,409,095 | $2,097,351,544 | $1,783,598,852 | $1,257,903,299 |
| Construction In Progress | $567,303,531 | $627,356,283 | $702,704,366 | $342,386,706 |
| Other Properties | $140,325,711 | $124,790,674 | $103,355,879 | $90,284,427 |
| Machinery Furniture Equipment | $1,021,888,873 | $867,467,510 | $717,600,568 | $610,825,720 |
| Buildings And Improvements | $29,623,807 | $29,779,788 | $26,402,108 | $23,532,513 |
| Land And Improvements | $570,267,174 | $447,957,288 | $233,535,932 | $190,873,934 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-24,044,039 | $-22,968,228 | $-20,807,430 | $-18,573,229 |
| Finished Goods | $114,319,291 | $110,308,510 | $129,639,854 | $106,656,716 |
| Work In Process | $58,458,533 | $61,316,658 | $43,980,957 | $34,632,408 |
| Raw Materials | $158,924,172 | $132,587,439 | $140,019,483 | $121,869,468 |
| Other Short Term Investments | - | $0 | $859,043 | $32,008,255 |
| Current Accrued Expenses | - | - | - | $14,303,244 |
| Other Inventories | - | - | - | $20,781,051 |
| Investmentsin Associatesat Cost | - | - | - | - |
Fetched: 2026-07-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $12,667,736 | $-180,978,305 | $-386,189,890 | $-160,356,676 |
| Operating Activities | ||||
| Operating Cash Flow | $328,107,547 | $178,662,672 | $120,667,495 | $118,490,640 |
| Cash Flow From Continuing Operating Activities | $328,107,547 | $178,662,672 | $120,667,495 | $118,490,640 |
| Operating Gains Losses | $-584,929 | $51,611 | $-408,304 | $-3,585,273 |
| Investing Activities | ||||
| Capital Expenditure | $-315,439,811 | $-359,640,977 | $-506,857,385 | $-278,847,316 |
| Investing Cash Flow | $-313,018,662 | $-355,790,765 | $-483,109,252 | $-278,644,311 |
| Cash Flow From Continuing Investing Activities | $-313,018,662 | $-355,790,765 | $-483,109,252 | $-278,644,311 |
| Net Other Investing Changes | - | - | $32,008,255 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $194,714,970 | $0 | $0 |
| Financing Cash Flow | $25,303,358 | $210,139,903 | $181,247,831 | $-51,079,247 |
| Cash Flow From Continuing Financing Activities | $25,303,358 | $210,139,903 | $181,247,831 | $-51,079,247 |
| Cash Dividends Paid | $-16,902,166 | $-16,581,028 | $-16,394,080 | $-15,483,425 |
| Common Stock Dividend Paid | $-16,902,166 | $-16,581,028 | $-16,394,080 | $-15,483,425 |
| Net Common Stock Issuance | $0 | $194,714,970 | $0 | $0 |
| Common Stock Issuance | $0 | $194,714,970 | $0 | $0 |
| Net Other Financing Charges | - | - | $-286,730 | - |
| Other | ||||
| Repayment Of Debt | $-129,833,683 | $-186,106,186 | $-85,947,921 | $-50,743,199 |
| Issuance Of Debt | $172,039,207 | $218,112,146 | $283,876,562 | $15,147,378 |
| End Cash Position | $149,791,245 | $112,707,868 | $79,827,954 | $262,346,572 |
| Beginning Cash Position | $112,707,868 | $79,827,954 | $262,346,572 | $471,429,014 |
| Effect Of Exchange Rate Changes | $-3,308,865 | $-131,896 | $-1,324,693 | $2,150,476 |
| Changes In Cash | $40,392,243 | $33,011,810 | $-181,193,926 | $-211,232,918 |
| Net Issuance Payments Of Debt | $42,205,524 | $32,005,961 | $197,928,641 | $-35,595,822 |
| Net Long Term Debt Issuance | $42,205,524 | $32,005,961 | $197,928,641 | $-35,595,822 |
| Long Term Debt Payments | $-129,833,683 | $-186,106,186 | $-85,947,921 | $-50,743,199 |
| Long Term Debt Issuance | $172,039,207 | $218,112,146 | $283,876,562 | $15,147,378 |
| Net Investment Purchase And Sale | $287,877 | $441,564 | $-4,805,596 | $35,555 |
| Net Business Purchase And Sale | $0 | $-200,711 | $-4,116,297 | $0 |
| Purchase Of Business | $0 | $-200,711 | $-4,116,297 | $0 |
| Net Intangibles Purchase And Sale | $-12,932,674 | $-12,582,864 | $-9,973,620 | $-9,287,761 |
| Purchase Of Intangibles | $-12,932,674 | $-12,582,864 | $-9,973,620 | $-9,287,761 |
| Net PPE Purchase And Sale | $-300,373,865 | $-343,448,755 | $-496,221,993 | $-269,392,104 |
| Sale Of PPE | $2,133,272 | $3,609,358 | $661,773 | $167,450 |
| Purchase Of PPE | $-302,507,137 | $-347,058,113 | $-496,883,766 | $-269,559,555 |
| Taxes Refund Paid | $-68,707,413 | $-73,702,252 | $-88,043,345 | $-29,577,930 |
| Interest Received Cfo | $1,651,565 | $1,471,499 | $1,057,461 | $862,484 |
| Interest Paid Cfo | $-7,982,566 | $-8,499,827 | $-3,615,093 | $-3,975,226 |
| Change In Working Capital | $58,063,992 | $-19,964,443 | $-117,537,550 | $-135,037,261 |
| Change In Payables And Accrued Expense | $104,587,671 | $-29,691,475 | $120,395,675 | $41,348,774 |
| Change In Payable | $104,587,671 | $-29,691,475 | $120,395,675 | $41,348,774 |
| Change In Account Payable | $104,587,671 | $-29,691,475 | $120,395,675 | $41,348,774 |
| Change In Inventory | $-47,545,585 | $14,114,002 | $-130,278,688 | $-123,141,403 |
| Change In Receivables | $1,021,906 | $-4,386,971 | $-107,654,536 | $-53,244,633 |
| Changes In Account Receivables | $1,021,906 | $-4,386,971 | $-107,654,536 | $-53,244,633 |
| Other Non Cash Items | $23,841,034 | $-1,141,186 | $19,225,827 | $8,014,680 |
| Provisionand Write Offof Assets | $3,358,183 | $4,108,269 | $2,575,983 | $-7,766,945 |
| Depreciation Amortization Depletion | $101,578,152 | $92,501,424 | $90,010,313 | $74,346,821 |
| Depreciation And Amortization | $101,578,152 | $92,501,424 | $90,010,313 | $74,346,821 |
| Amortization Cash Flow | $15,657,757 | $17,703,863 | $18,222,271 | $16,562,677 |
| Amortization Of Intangibles | $15,657,757 | $17,703,863 | $18,222,271 | $16,562,677 |
| Depreciation | $85,920,395 | $74,797,561 | $71,788,042 | $57,784,144 |
| Pension And Employee Benefit Expense | $-511,526 | $144,512 | $138,777 | $-3,440,761 |
| Net Income From Continuing Operations | $216,889,529 | $183,837,577 | $217,402,203 | $215,209,291 |
| Sale Of Business | - | - | $0 | $0 |
| Earnings Losses From Equity Investments | - | - | $0 | $0 |
| Sale Of Investment | - | - | - | $35,555 |
| Gain Loss On Sale Of Business | - | - | - | - |
Fetched: 2026-07-16